CDK6—a review of the past and a glimpse into the future: from cell-cycle control to transcriptional regulation

Cited by (206)

Items 101–200 of 206

1. CDKN2A (p16INK4A) affects the anti‑tumor effect of CDK inhibitor in somatotroph adenomas
   Yiyuan Chen, Zhenye Li, Qiuyue Fang, Hongyun Wang, Chuzhong Li, Hua Gao, Yazhuo Zhang · 2020 · International Journal of Molecular Medicine
2. Cyclin-dependent kinase inhibition: an opportunity to target protein-protein interactions
   Mark Alan Klein · 2019 · Advances in protein chemistry and structural biology
3. The Effect of CDK6 Expression on DNA Methylation and DNMT3B Regulation
   Gerwin Heller, Sofie Nebenfuehr, Florian Bellutti, Huriye Ünal, Markus Zojer, Lisa Scheiblecker, Veronika Sexl, Karoline Kollmann · 2020 · iScience
4. The driving power of the cell cycle: cyclin-dependent kinases, cyclins and their inhibitors
   Márk Híveš, Jana Jurečeková, KLAUDIA HÍVEŠ HOLEČKOVÁ, Jan Kliment, Monika Kmeťová Sivoňová · 2023 · Bratislavské lekárske listy/Bratislava medical journal
5. Progression after First-Line Cyclin-Dependent Kinase 4/6 Inhibitor Treatment: Analysis of Molecular Mechanisms and Clinical Data
   Federica Villa, Alessandra Crippa, Davide Pelizzoni, Alessandra Ardizzoia, Giulia Scartabellati, Cristina Corbetta, Eleonora Cipriani, Marialuisa Lavitrano, Antonio Ardizzoia · 2023 · International Journal of Molecular Sciences
6. A robust approach for the generation of functional hematopoietic progenitor cell lines to model leukemic transformation
   Eszter Doma, Isabella Maria Mayer, Tania Brandstoetter, Barbara Maurer, Reinhard Grausenburger, Ingeborg Menzl, Markus Zojer, Andrea Hoelbl‐Kovacic, Leif Carlsson, Gerwin Heller et al. · 2020 · Blood Advances
7. A C/ebpα isoform specific differentiation program in immortalized myelocytes
   María-Paz García-Cuéllar, Selin Akan, Robert K. Slany · 2023 · Leukemia
8. Molecules Inducing Specific Cyclin-Dependent Kinase Degradation and their Possible Use in Cancer Therapy
   Mingming Zheng, Xiaoyu Zhang, Weijiao Chen, Fei Xia, Huanaoyu Yang, Kai Yuan, Peng Yang · 2024 · Future Medicinal Chemistry
9. Genetics and epigenetics of leukemia and lymphoma: from knowledge to applications, meeting report of the Josep Carreras Leukaemia Research Institute
   Maribel Parra, Maria João Baptista, Eulàlia Genescà, Pere Llinàs‐Arias, Manel Esteller · 2020 · Hematological Oncology
10. Control of the Cell Cycle
    Marcos Malumbres · 2020 · Elsevier eBooks
11. Screening of immune-related differentially expressed genes from primary lymphatic organs of broilers fed with probiotic bacillus cereus PAS38 based on suppression subtractive hybridization
    Jiajun Li, Wanqiang Li, Zhenhua Wang, Abdul Khalique, Junrui Wang, Miao Yang, Xueqin Ni, Dong Zeng, Dongmei Zhang, Yan Zeng et al. · 2020 · PLoS ONE
12. Single-nucleus multiomics reveals the gene regulatory networks underlying sex determination of murine primordial germ cells
    Adriana K. Alexander, Karina F. Rodriguez, Yuying Chen, Ciro Maurizio Amato, Martin Andres Estermann, Barbara Nicol, Xin Xu, Humphrey Hung‐Chang Yao · 2025 · eLife
13. Synergistic Antiproliferative Effect of Ribociclib (LEE011) and 5-Fluorouracil on Human Colorectal Cancer
    Pai‐Mei Lin, Hui-Ming Lee, Chung‐I Huang, Tzong-Shyuan Tai, Jian‐Han Chen, Chih‐I Chen, Yu‐Chieh Su · 2020 · Anticancer Research
14. CDC37L1 acts as a suppressor of migration and proliferation in gastric cancer by down-regulating CDK6
    Li Li, Xinyi Tao, Yandong Li, Yong Gao, Qinchuan Li · 2021 · Journal of Cancer
15. Dysregulation of miR-1-3p: An Early Event in Colitis-Associated Dysplasia
    Mariana Franco Fragoso, Geysson Javier Fernández, Lisa Vanderveer, Harry S. Cooper, Michael J. Slifker, Margie L. Clapper · 2022 · International Journal of Molecular Sciences
16. RETRACTED: Role and mechanism of Circ‐PDE7B in the formation of keloid
    Yueling Tang, Xiaojing Li · 2023 · International Wound Journal · Retracted
17. Self-assembled fructo-oligosaccharide conjugated ferulic acid microparticle: Anticancer, anti-inflammatory and immunomodulatory effects
    Eldin M. Johnson, Late Rasu Jayabalan, S. K. Patra, Joo-Won Suh · 2024 · Journal of Drug Delivery Science and Technology
18. Single-cell cloning of human T-cell lines reveals clonal variation in cell death responses to chemotherapeutics
    Kathleen M. Hanlon, Alex Thompson, Lorena Pantano, John N. Hutchinson, Arshed Al‐Obeidi, Shu Wang, Meghan Bliss‐Moreau, Jennifer D. Helble, Gabriela Alexe, Kimberly Stegmaier et al. · 2019 · Cancer Genetics
19. CDK6 is stimulated by hyperthermia and protects gastric cancer cells from hyperthermia‑induced damage
    Guanghui Liu, Hongchao Zhao, Qingqing Ding, Haohao Li, Tao Liu, Hongwei Yang, Yuanhua Liu · 2021 · Molecular Medicine Reports
20. In silico Drug Repurposing of FDA-Approved Artemisinins as Potent Chemotherapeutics Targeting Bcl-2, CDK-6 & VEGFR-2: Density Functional Exploration and Molecular Docking Study
    2020 · Biointerface Research in Applied Chemistry
21. Advances in Cutaneous Melanoma Therapy: The Emerging Role of CDK4/6 Inhibitors
    Uriel Kim, Thomas S. McCormick, Ankit Mangla, Kevin D. Cooper, Gary K. Schwartz, Akihiro Yoshida · 2025 · Pharmacological Research
22. Identification and Functional Analysis of the G1 Phase Cyclin Dependent Kinase Gene Hc-CDK6 in Pearl Mussels (Hyriopsis cumingii)
    Shangle Feng, XueNan Li, He Wang, Wenjuan Li, Zhiyi Bai · 2022 · Frontiers in Marine Science
23. Notch signaling defects in NK cells in patients with cancer
    Gulnur K. Zakiryanova, Елена Анатольевна Кустова, Nataliya T. Urazalieva, Emile T. Baimukhametov, Valeriy A. Makarov, Gulmariya M. Turaly, Galina V. Shurin, Zarema M. Biyasheva, Narymzhan N. Nakisbekov, Michael R. Shurin · 2020 · Cancer Immunology Immunotherapy
24. Dual targeting of CDK6 and LSD1 is synergistic and overcomes differentiation blockade in AML
    Lise M. Brault, Edwige Voisset, Mathieu Desaunay, Antonia Boudet, Paraskevi Kousteridou, Sébastien Letard, Nadine Carbuccia, Armelle Goubard, Rémy Castellano, Yves Collette et al. · 2025 · EMBO Molecular Medicine
25. Primary cilia as architects of the neocortex: Roles in brain development, function, and microcephaly
    Oskar Kaaber Thomsen, Jindřiška Leischner Fialová, Canan Doğanlı, Cristian Herrera-Cid, Kjeld Møllgård, Alexandre Benmerah, Lars Allan Larsen, Søren Christensen · 2025 · Developmental Cell
26. Knockdown of Fzr inhibited the growth of Nilaparvata lugens by blocking endocycle
    Haoli Gao, Xiaowei Yuan, Jingting Wang, Yangyang Yan, Xinyu Zhang, Tianshun He, Xumin Lin, Huihui Zhang, Zewen Liu · 2024 · Pest Management Science
27. Interactions between genes altered during cardiotoxicity and neurotoxicity in zebrafish revealed using induced network modules analysis
    Manusmriti Agarwal, Ankush Sharma, Andrea Kagoo, Anamika Bhargava · 2023 · Scientific Reports
28. The hsa-miR-3613–5p, a potential oncogene correlated with diagnostic and prognostic merits in kidney renal clear cell carcinoma
    Mohsen Ahmadi, Parisa Najari-Hanjani, Roya Ghaffarnia, Sayyed Mohammad Hossein Ghaderian, Pegah Mousavi, Soudeh Ghafouri‐Fard · 2023 · Pathology - Research and Practice
29. Anticancer, anti-inflammatory, and immune modulatory activity of ferulic acid fructo-oligosaccharide conjugated microparticle
    Eldin Maliyakkal Johnson, R. Jayabalan, Samir Kumar Patra, Joo‐Won Suh · 2023 · bioRxiv (Cold Spring Harbor Laboratory)
30. Single-nucleus multiomics reveals the gene-regulatory networks underlying sex determination of murine primordial germ cells
    Adriana K. Alexander, Karina F. Rodriguez, Yuying Chen, Ciro Maurizio Amato, Martin Andres Estermann, Xin Miao Xu, Humphrey Hung‐Chang Yao · 2024 · eLife
31. Single-nucleus multiomics reveals the gene regulatory networks underlying sex determination of murine primordial germ cells
    Adriana K. Alexander, Karina F. Rodriguez, Yuying Chen, Ciro Maurizio Amato, Martin Andres Estermann, Barbara Nicol, Xin Xu, Humphrey Hung‐Chang Yao · 2024 · eLife
32. Cdk6’s functions are critically regulated by its unique C-terminus
    Alessia Schirripa, Helge Schöppe, Sofie Nebenfuehr, Markus Zojer, Thorsten Klampfl, Valentina Kugler, Belinda S. Schmalzbauer, Huriye Ceylan, Iris Z. Uras, Lisa Scheiblecker et al. · 2024 · iScience
33. BET Bromodomain Inhibition Reverses CDK4/6 Inhibitor Resistance in Estrogen Receptor–Positive Breast Cancer via Induction of miR-34a-5p
    Renyan Liu, Xin Wang, Timothy B. Branigan, Daryl Griffin, Caoibhne McSweeney, Jie Hao, Constantia Pantelidou, Zachary T. Herbert, Heta Jadhav, Geoffrey Ira Shapiro · 2025 · Clinical Cancer Research
34. Gene regulatory network inference with popInfer reveals the dynamic regulation of hematopoietic stem cell quiescence
    Megan K. Rommelfanger, Marthe Behrends, Yu-Lin Chen, Jonathan Martinez, Nikith Kurella, Nino Geisler, Deepthi Guturu, Martin Bens, Lingyun Xiong, Zijin Xiang et al. · 2025 · iScience
35. Cell-cycle targeted cancer therapy: clinical advances, biological gaps, and the emergence of selective CDK4 inhibitors
    Ava Safaroghli‐Azar, Laychiluh Bantie Mekonnen, Jimma Likisa Lenjisa, Robert W. Milne, Shudong Wang · 2026 · Journal of Hematology & Oncology
36. Advantages of PROTACs in achieving selective degradation of homologous protein families
    Luxi Yang, Xinfei Mao, Jingyi Zhang, Jing Shu, Wenhai Huang, Xiaowu Dong, Yinqiao Chen, Mingfei Wu · 2026 · Beilstein Journal of Organic Chemistry
37. Noncoding RNA Linc00475 promotes the proliferation of colorectal cancer cells by targeting miR‐107/CDK6 axis
    Dongqing Li, Mingya Peng, Juying Zhou · 2024 · Journal of Biochemical and Molecular Toxicology
38. Molecular characterization of the cyclin-dependent protein kinase 6 in whitefish (Coregonus lavaretus) and its potential interplay with miR-34a
    Alicja Łakomiak, Paweł Brzuzan, EWA JAKIMIUK, Maciej Florczyk, Maciej Woźny · 2019 · Gene
39. Design, Synthesis, and Antitumor Activity Evaluation of Artemisinin Bivalent Ligands
    Hui Zhong, Qi Jiang, Cong Wu, Huanghe Yu, Bin Li, Xu-Dong Zhou, Ronggeng Fu, Wei Wang, Wenbing Sheng · 2024 · Molecules
40. A robust platform for BaEVRless-lentiviral synthesis and primary natural killer cell transduction
    Yi-Jun Lan, Quoc Viet Nguyen, Tsu-Lan Chao, Kuo-Lun Yeh, Steven Lin · 2024 · bioRxiv (Cold Spring Harbor Laboratory)
41. Structural requirements for the specific binding of CRABP2 to cyclin D3
    Martyna W. Pastok, Charles W.E. Tomlinson, Shannon Turberville, Abbey M. Butler, Arnaud Baslé, Martin E. M. Noble, Jane Endicott, Ehmke Pohl, Natalie J. Tatum · 2024 · Structure
42. Genetic analysis in a consanguineous MCPH family revealed a refinement of the MCPH12 locus and a founder effect of the recurrent CDK6 variant [c.589G>A, p.(Ala197Thr)] in the Pakistani population
    Muzammil Ahmad Khan, Jasmin Blatterer, Markus Kuster, Lukas Kaufmann, Peter M. Kroisel, John B. Vincent, Muhammad Zubair, Muhammad Muzammal, Nisar Ahmad, Shakil Abbas et al. · 2025 · Journal of Genetics
43. Leiomodin 1 haploinsufficiency promotes smooth muscle cell proliferation and increases neointimal lesion size
    Sara A. Wennersten, Hongxia Wang, J. Lee Franklin, Vivek Nanda · 2025 · Vascular Pharmacology
44. Genome-wide CRISPR screens in primary human natural killer cells identify countermeasures against immunosuppressive environment
    Quoc Viet Nguyen, Yi-Jun Lan, Jason Cheng-Yu Chang, Hsin-An Shih, Jenifer Faustine, Cheng-Chieh Chen, Shu-Yu Ho, Ching-Wen Cheng, Tsu-Lan Chao, Steven Lin · 2026 · Nature Communications
45. CDK6 as a Biomarker for Immunotherapy, Drug Sensitivity, and Prognosis in Bladder Cancer: Bioinformatics and Immunohistochemical Analysis
    Xiaojie Zhao, Xin Yu, Wen Ge Li, Zhiyuan Chen, Tingting Niu, Xiaodong Weng, Lei Wang, Xiuheng Liu · 2024 · International Journal of Medical Sciences
46. Silencing of DHX32 increases the proliferation of liver cancer cells
    Minjing Cai, Jianhui Zhu, Jianquan He, Zhongying Zhang, Xianming Liang · 2020 · Translational Cancer Research
47. CDK6 Immunophenotype Implicates Potential Therapeutic Application of CDK4/6 Inhibitors in Urothelial Carcinoma
    Ran Sun, Xuemei Wang, Leichao Zhang, Yu Gu, Shaojuan Yang, Liping Wang, Xueju Wang · 2022 · Frontiers in Oncology
48. Vasopressin Receptors in Blood Vessels and Proliferation of Endotheliocytes
    Igor I. Khegay · 2021 · Russian Journal of Bioorganic Chemistry
49. In Silico Drug Repurposing of 9H-Thioxanthene Based FDA-Approved Drugs as Potent Chemotherapeutics Targeting VEGFR-2 and COX-2
    2022 · Biointerface Research in Applied Chemistry
50. FEZF1-AS1 drives autophagy-mediated progression of colon cancer and reduces chemosensitivity through inhabiting the PI3K/AKT/mTOR signaling pathway
    Xiaoping Yang, Zuohui Yuan, Lingzhu Gou, Long Cheng, Zirui Wang, Pingfan Wu, Xiaochun Wang, Xueni Ma, Tiantian Ma, Yi Yu et al. · 2025 · Frontiers in Genetics
51. Expression of the CXCR4 S338X Variant Improves Anti‐Leukemia Efficacy of Anti‐ CD19 CAR ‐T Cells
    Yushu Mao, Xiaodan Wang, Chunhui Jin, Zhifeng Wei, Qing Ding, Ke‐Ke Zhang, Bo‐Wen Dong, K. Zheng, Yufei Hou, Tao Zhang et al. · 2025 · Cancer Science
52. Microneedle–peptide biosensor platform for multiplexed profiling of cyclin-dependent kinase activities in cancer cell lines
    Chloé Royet, Lennard Lecki, Sébastien Diot, Saïd Jebors, Karine Puget, Sanjiv Sharma, May Catherine Morris · 2026 · Sensors and Actuators Reports
53. High Histological Entropy Is Correlated with Poor Overall Survival and Death Within the First 2 Years in Diffuse Large B-Cell Lymphoma
    Joaquim Carreras, Yara Yukie Kikuti, Shunsuke Nagase, Giovanna Roncador, Haruka Ikoma, Atsushi Ito, Makoto Orita, Sakura Tomita, Yuki Tanigaki, Akihisa Ueno et al. · 2026 · Cancers
54. XTP1 facilitates the growth and development of gastric cancer by activating CDK6
    Kang Li, Rulan Ma, Lei Meng, Qing Wang, Jun Cao, Dawei Yuan, Tuanhe Sun, Kang Li, Nan Hao, Haonan Wang et al. · 2023 · Annals of Translational Medicine
55. Clinical implementation of biomarkers and signaling pathway as novel targeted therapeutics in breast cancer
    Rama Kadamb, Saurabh Singh · 2023 · Elsevier eBooks
56. The adaptation of 3T3 cells to simulated microgravity by retrieving the major cell cycle-related protein expression during long-term in vitro proliferation
    Chi Nguyen Quynh Ho, Hoàng Nghĩa Sơn, Hanh Hong Nguyen, Han Thai Minh Nguyen, Han Thi Truong, Quynh Thi Truc Nguyen, Cang Ngoc Ly, Lê Thành Long · 2024 · Tissue and Cell
57. Potential Target of CDK6 Signaling Pathway for Cancer Treatment
    Rajesh Basnet, Obed Boadi Amissah, Buddha Bahadur Basnet, Rongqi Huang, Yirong Sun, Jean de Dieu Habimana, Zhiyuan Li · 2024 · Current Drug Targets
58. Molecular basis of urostyle development in frogs: genes and gene regulation underlying an evolutionary novelty
    Gayani Senevirathne, Neil H. Shubin · 2024 · Open Biology
59. Aluminum chloride induces G0/G1 phase arrest via regulating the reactive oxygen species-depended non-canonical STAT1 pathway in hFOB1.19 cells
    Y Zhao, F Li, S Li, J Ji, Wenjuan Qiao, J Fang · 2022 · Human & Experimental Toxicology
60. A cutting-edge approach unravels a novel role for CDK6 in leukemic progenitor cells
    Eszter Doma, Isabella Maria Mayer, Tania Brandstoetter, Barbara Maurer, Reinhard Grausenburger, Ingeborg Menzl, Markus Zojer, Andrea Hoelbl‐Kovacic, Leif Carlsson, Gerwin Heller et al. · 2020 · bioRxiv (Cold Spring Harbor Laboratory)
61. Transcriptomic analysis of TGFβ-mediated fibrosis in primary human Tenon’s fibroblasts
    Zoe Pasvanis, Antony Boynes, Roy C. K. Kong, Elsa C. Chan, Raymond C.B. Wong, Jennifer C. Fan Gaskin · 2024 · bioRxiv (Cold Spring Harbor Laboratory)
62. Molecular Basis of Urostyle Development: Genes and Gene Regulation Underlying an Evolutionary Novelty
    Gayani Senevirathne, Neil H. Shubin · 2021 · bioRxiv (Cold Spring Harbor Laboratory)
63. Identification of Hub Gene and Potential Drugs for Enzalutamide Resistant Castration-Resistant Prostate Cancer Depend On Bioinformatics Analysis
    Xi Chen, Yechen Wu, Xinan Wang, Chengdang Xu, Licheng Wang, Yicong Yao, Denglong Wu, Gang Wu · 2021 · Research Square
64. MSCs‑derived exosomes attenuate ischemia-reperfusion brain injury and inhibit microglia apoptosis via exosomal miR-26a-5p mediated suppression of CDK6
    Chang Cheng, Xiuying Chen, Yuhan Wang, Wenchao Cheng, Xuzheng Zuo, Weiju Tang, Wen Huang · 2020
65. Targeting MDM2, the antagonist of the tumor suppressor p53
    Anusha Sriraman · 2018
66. Simulated microgravity altered the cell cycle progression of porcine granulosa cells
    Truong Xuan Dai, Hoàng Nghĩa Sơn, Lê Thành Long · 2022 · Vietnam Journal of Biotechnology
67. CDK6 activity in a recurring convergent kinase network motif
    Christina G. Gangemi, Rahkesh T Sabapathy, Harald Janovjak · 2023 · The FASEB Journal
68. Data from CDK6 Is a Therapeutic Target in Myelofibrosis
    Avik Dutta, Dipmoy Nath, Yue Yang, Bao T. Le, Golam Mohi · 2023
69. A C/ebpα isoform-specific differentiation program in primary myelocytes
    María-Paz García-Cuéllar, Selin Akan, Robert K. Slany · 2023 · bioRxiv (Cold Spring Harbor Laboratory)
70. Differential Expression and Prognostic Significance of CDK1 and CDK6 in Breast Cancer: A Multi-Omics Approach
    Md. Wahidul Islam, Fatema Tuj Johora Fariha, Md. Zabir Ahmed, Jannatul Ferdous, Hafeza Bhuiyan Lota, Md. Jubayer Hossain, Pritom Kundu, Muhibullah Shahjahan, Md. Shohel Hossain · 2024 · Research Square
71. Single-nucleus multiomics reveals the gene-regulatory networks underlying sex determination of murine primordial germ cells
    Adriana K. Alexander, Karina F. Rodriguez, Yuying Chen, Ciro Maurizio Amato, Martin Andres Estermann, Barbara Nicol, Xin Xu, Humphrey Hung‐Chang Yao · 2025 · eLife
72. Loss of Leiomodin1 Enhances Smooth Muscle Cell Proliferation and Neointima Formation
    Sara A. Wennersten, Hongxia Wang, J. Lee Franklin, Vivek Nanda · 2025 · SSRN Electronic Journal
73. Dual CDK6 and CDK9 inhibitors as anti-psoriasis agents: Design, synthesis, and anti-inflammatory activity
    Yiming Ru, Fang Zhao, Haojie Zuo, Xiuxiu Gao, Yaoyao Yan, Xiaodong Ma, Yang Wang · 2025 · Bioorganic & Medicinal Chemistry Letters
74. The Biotechnological Approach to Enhancing the Antioxidant Activity of Red Andong (Cordyline Fruticosa (L) a. Chev.)
    Fahrauk Faramayuda, Soraya Riyanti, Melisa Puspitasari, Nursafira Khairunnisa Ismail, Jean Bobby Venando, Dadan Suryasaputra, Sukrasno Sukrasno, Rian Maulana Muttaqin · 2025 · SSRN Electronic Journal
75. Discovery of placental microRNAs associated with maternal insulin sensitivity during pregnancy
    Sana Majid, Imad Soukar, Frédérique White, Catherine Allard, François Aguet, Kristin Ardlie, José C. Florez, Andrea G. Edlow, Pierre‐Étienne Jacques, S. Ananth Karumanchi et al. · 2025 · Placenta
76. Additional file 1 of CDK6-PI3K signaling axis is an efficient target for attenuating ABCB1/P-gp mediated multi-drug resistance (MDR) in cancer cells
    Zhang, Lei, Li, Yidong, Hu, Chaohua, Yangmin Chen, Chen, Zhuo, Chen, Zhe-Sheng, Zhang, Jian-Ye, Fang, Shuo · 2022 · Figshare
77. Additional file 3 of CDK6 is upregulated and may be a potential therapeutic target in enzalutamide-resistant castration-resistant prostate cancer
    Chen, Xi, Wu, Yechen, Wang, Xinan, Chengdang Xu, Wang, Licheng, Jingang Jian, Wu, Denglong, Gang Wu · 2022 · Figshare
78. Additional file 7 of CDK6 is upregulated and may be a potential therapeutic target in enzalutamide-resistant castration-resistant prostate cancer
    Chen, Xi, Wu, Yechen, Wang, Xinan, Chengdang Xu, Wang, Licheng, Jingang Jian, Wu, Denglong, Gang Wu · 2022 · Figshare
79. Additional file 2 of CDK6 is upregulated and may be a potential therapeutic target in enzalutamide-resistant castration-resistant prostate cancer
    Chen, Xi, Wu, Yechen, Wang, Xinan, Chengdang Xu, Wang, Licheng, Jingang Jian, Wu, Denglong, Gang Wu · 2022 · Figshare
80. Additional file 4 of CDK6 is upregulated and may be a potential therapeutic target in enzalutamide-resistant castration-resistant prostate cancer
    Chen, Xi, Wu, Yechen, Wang, Xinan, Chengdang Xu, Wang, Licheng, Jingang Jian, Wu, Denglong, Gang Wu · 2022 · Figshare
81. Additional file 4 of CDK6-PI3K signaling axis is an efficient target for attenuating ABCB1/P-gp mediated multi-drug resistance (MDR) in cancer cells
    Zhang, Lei, Li, Yidong, Hu, Chaohua, Yangmin Chen, Chen, Zhuo, Chen, Zhe-Sheng, Zhang, Jian-Ye, Fang, Shuo · 2022 · Figshare
82. Additional file 5 of CDK6 is upregulated and may be a potential therapeutic target in enzalutamide-resistant castration-resistant prostate cancer
    Chen, Xi, Wu, Yechen, Wang, Xinan, Chengdang Xu, Wang, Licheng, Jingang Jian, Wu, Denglong, Gang Wu · 2022 · Figshare
83. Additional file 6 of CDK6-PI3K signaling axis is an efficient target for attenuating ABCB1/P-gp mediated multi-drug resistance (MDR) in cancer cells
    Zhang, Lei, Li, Yidong, Hu, Chaohua, Yangmin Chen, Chen, Zhuo, Chen, Zhe-Sheng, Zhang, Jian-Ye, Fang, Shuo · 2022 · Figshare
84. Additional file 6 of CDK6 is upregulated and may be a potential therapeutic target in enzalutamide-resistant castration-resistant prostate cancer
    Chen, Xi, Wu, Yechen, Wang, Xinan, Chengdang Xu, Wang, Licheng, Jingang Jian, Wu, Denglong, Gang Wu · 2022 · Figshare
85. Additional file 1 of CDK6 is upregulated and may be a potential therapeutic target in enzalutamide-resistant castration-resistant prostate cancer
    Chen, Xi, Wu, Yechen, Wang, Xinan, Chengdang Xu, Wang, Licheng, Jingang Jian, Wu, Denglong, Gang Wu · 2022 · Figshare
86. Additional file 7 of CDK6-PI3K signaling axis is an efficient target for attenuating ABCB1/P-gp mediated multi-drug resistance (MDR) in cancer cells
    Zhang, Lei, Li, Yidong, Hu, Chaohua, Yangmin Chen, Chen, Zhuo, Chen, Zhe-Sheng, Jianye Zhang, Fang, Shuo · 2022 · Figshare
87. Additional file 8 of CDK6 is upregulated and may be a potential therapeutic target in enzalutamide-resistant castration-resistant prostate cancer
    Chen, Xi, Wu, Yechen, Wang, Xinan, Chengdang Xu, Wang, Licheng, Jingang Jian, Wu, Denglong, Gang Wu · 2022 · Figshare
88. Additional file 8 of CDK6-PI3K signaling axis is an efficient target for attenuating ABCB1/P-gp mediated multi-drug resistance (MDR) in cancer cells
    Zhang, Lei, Li, Yidong, Hu, Chaohua, Yangmin Chen, Chen, Zhuo, Chen, Zhe-Sheng, Zhang, Jian-Ye, Fang, Shuo · 2022 · Figshare
89. Additional file 5 of CDK6-PI3K signaling axis is an efficient target for attenuating ABCB1/P-gp mediated multi-drug resistance (MDR) in cancer cells
    Zhang, Lei, Li, Yidong, Hu, Chaohua, Yangmin Chen, Chen, Zhuo, Chen, Zhe-Sheng, Zhang, Jian-Ye, Fang, Shuo · 2022 · Figshare
90. Additional file 9 of CDK6 is upregulated and may be a potential therapeutic target in enzalutamide-resistant castration-resistant prostate cancer
    Chen, Xi, Wu, Yechen, Wang, Xinan, Chengdang Xu, Wang, Licheng, Jingang Jian, Wu, Denglong, Gang Wu · 2022 · Figshare
91. Additional file 10 of CDK6 is upregulated and may be a potential therapeutic target in enzalutamide-resistant castration-resistant prostate cancer
    Chen, Xi, Wu, Yechen, Wang, Xinan, Chengdang Xu, Wang, Licheng, Jingang Jian, Wu, Denglong, Gang Wu · 2022 · Figshare
92. Additional file 3 of CDK6-PI3K signaling axis is an efficient target for attenuating ABCB1/P-gp mediated multi-drug resistance (MDR) in cancer cells
    Zhang, Lei, Li, Yidong, Hu, Chaohua, Yangmin Chen, Chen, Zhuo, Chen, Zhe-Sheng, Zhang, Jian-Ye, Fang, Shuo · 2022 · Figshare
93. Additional file 2 of CDK6-PI3K signaling axis is an efficient target for attenuating ABCB1/P-gp mediated multi-drug resistance (MDR) in cancer cells
    Zhang, Lei, Li, Yidong, Hu, Chaohua, Yangmin Chen, Chen, Zhuo, Chen, Zhe-Sheng, Zhang, Jian-Ye, Fang, Shuo · 2022 · Figshare
94. CDK4 and CDK6 variants in patients with primary microcephaly lead to cell cycle defects and mitochondria-induced apoptosis
    Esra Işık, Mohammad Faraz Zafeer, Güney Bademci, Memoona Ramzan, Turkan Turkut Tan, LéShon Peart, Yusuf Can Dogan, Mehmet Mert Topaloglu, Ozgur Cogulu, Nihal Karadaş et al. · 2026 · Journal of Medical Genetics
95. Continuous low-intensity ultrasound influences the transcriptomic profile in M1 macrophages by downregulating inflammation and promoting M2-like markers
    Shahid Khan, Owen Trippany, Anuradha Subramanian, Satyaki Roy · 2026 · Scientific Reports
96. Integrated Network Pharmacology and Dynamics Approach to Evaluate Phytochemicals From Glycyrrhiza glabra Against Nipah Virus
    Saurav Kumar Mishra, Tabsum Chhetri, Anshuman Chandra, Karthik V․, S.M. Anandalwar, Kusum Gurung, John J. Georrge · 2026 · ChemistrySelect
97. WWOX/HIF1A Balance Delineates Context-Dependent Molecular States in Breast Cancer Subtypes and Ovarian Carcinoma
    Raneem Y. Hammouz, Kinga Maciejek, Andrzej Kazimierz Bednarek · 2026 · International Journal of Molecular Sciences
98. Alternative Splicing in Cyclin‐Dependent Kinase 4/6 Inhibitor Resistance in Estrogen Receptor‐Positive Breast Cancer
    Yuqiu Cui, Jia Xie, Jiale Cai, Yue Si, Hairong Huang, Shiyi Yu, Haibo Sun · 2026 · Drug Development Research
99. Resistance and resistance markers of CDK4/6 inhibitors
    Suman Karadagatla, Narendra Vijay Tirpude, G. Swetha Kumari, Abhay Garg, Anamika Sharma · 2026 · Elsevier eBooks
100. Apigenin Alleviates Ligamentum Flavum Ossification by Dual-Targeting CA9 and CDK6 and Modulating Calcium/PI3K–Akt Signaling
     Y.H. Zhang, Yihuang Chen, Guohao Liu, Huan Liu · 2026 · OMICS A Journal of Integrative Biology